Milnacipran Pierre Fabre Medicament

ืžื“ื™ื ื”: ื”ืื™ื—ื•ื“ ื”ืื™ืจื•ืคื™

ืฉืคื”: ื™ื•ื•ื ื™ืช

ืžืงื•ืจ: EMA (European Medicines Agency)

ืงื ื” ืืช ื–ื”

ื”ื•ืจื“ ืฆื™ื‘ื•ืจ ื“ื•"ื— ื”ืขืจื›ื” (PAR)
20-11-2009

ืžืจื›ื™ื‘ ืคืขื™ืœ:

milnacipran

ื–ืžื™ืŸ ืž:

Pierre Fabre Medicament

INN (ืฉื ื‘ื™ื ืœืื•ืžื™):

milnacipran

ืื™ื–ื•ืจ ืชืจืคื•ื™ื˜ื™:

ฮ™ฮฝฮฟฮผฯ…ฮฑฮปฮณฮฏฮฑ

ืžืฆื‘ ืื™ืฉื•ืจ:

ฮ‘ฯฮฝฮฎฮธฮทฮบฮต

ืžื•ืฆืจื™ื ื“ื•ืžื™ื

ืžืจื›ื™ื‘ ืคืขื™ืœ milnacipran

milnacipran

ื™ืฆืจืŸ ืื• ืžื—ื–ื™ืง ื‘ืจืฉื™ื•ืŸ Pierre Fabre Medicament

Pierre Fabre Medicament

INN (ืฉื ื‘ื™ื ืœืื•ืžื™) milnacipran

milnacipran

ืžืกืžื›ื™ื ื‘ืฉืคื•ืช ืื—ืจื•ืช

ืฆื™ื‘ื•ืจ ื“ื• ืฆื™ื‘ื•ืจ ื“ื•"ื— ื”ืขืจื›ื” ื‘ื•ืœื’ืจื™ืช 20-11-2009
ืฆื™ื‘ื•ืจ ื“ื• ืฆื™ื‘ื•ืจ ื“ื•"ื— ื”ืขืจื›ื” ืกืคืจื“ื™ืช 20-11-2009
ืฆื™ื‘ื•ืจ ื“ื• ืฆื™ื‘ื•ืจ ื“ื•"ื— ื”ืขืจื›ื” ืฆืณื›ื™ืช 20-11-2009
ืฆื™ื‘ื•ืจ ื“ื• ืฆื™ื‘ื•ืจ ื“ื•"ื— ื”ืขืจื›ื” ื“ื ื™ืช 20-11-2009
ืฆื™ื‘ื•ืจ ื“ื• ืฆื™ื‘ื•ืจ ื“ื•"ื— ื”ืขืจื›ื” ื’ืจืžื ื™ืช 20-11-2009
ืฆื™ื‘ื•ืจ ื“ื• ืฆื™ื‘ื•ืจ ื“ื•"ื— ื”ืขืจื›ื” ืืกื˜ื•ื ื™ืช 20-11-2009
ืฆื™ื‘ื•ืจ ื“ื• ืฆื™ื‘ื•ืจ ื“ื•"ื— ื”ืขืจื›ื” ืื ื’ืœื™ืช 20-11-2009
ืฆื™ื‘ื•ืจ ื“ื• ืฆื™ื‘ื•ืจ ื“ื•"ื— ื”ืขืจื›ื” ืฆืจืคืชื™ืช 20-11-2009
ืฆื™ื‘ื•ืจ ื“ื• ืฆื™ื‘ื•ืจ ื“ื•"ื— ื”ืขืจื›ื” ืื™ื˜ืœืงื™ืช 20-11-2009
ืฆื™ื‘ื•ืจ ื“ื• ืฆื™ื‘ื•ืจ ื“ื•"ื— ื”ืขืจื›ื” ืœื˜ื‘ื™ืช 20-11-2009
ืฆื™ื‘ื•ืจ ื“ื• ืฆื™ื‘ื•ืจ ื“ื•"ื— ื”ืขืจื›ื” ืœื™ื˜ืื™ืช 20-11-2009
ืฆื™ื‘ื•ืจ ื“ื• ืฆื™ื‘ื•ืจ ื“ื•"ื— ื”ืขืจื›ื” ื”ื•ื ื’ืจื™ืช 20-11-2009
ืฆื™ื‘ื•ืจ ื“ื• ืฆื™ื‘ื•ืจ ื“ื•"ื— ื”ืขืจื›ื” ืžืœื˜ื™ืช 20-11-2009
ืฆื™ื‘ื•ืจ ื“ื• ืฆื™ื‘ื•ืจ ื“ื•"ื— ื”ืขืจื›ื” ื”ื•ืœื ื“ื™ืช 20-11-2009
ืฆื™ื‘ื•ืจ ื“ื• ืฆื™ื‘ื•ืจ ื“ื•"ื— ื”ืขืจื›ื” ืคื•ืœื ื™ืช 20-11-2009
ืฆื™ื‘ื•ืจ ื“ื• ืฆื™ื‘ื•ืจ ื“ื•"ื— ื”ืขืจื›ื” ืคื•ืจื˜ื•ื’ืœื™ืช 20-11-2009
ืฆื™ื‘ื•ืจ ื“ื• ืฆื™ื‘ื•ืจ ื“ื•"ื— ื”ืขืจื›ื” ืจื•ืžื ื™ืช 20-11-2009
ืฆื™ื‘ื•ืจ ื“ื• ืฆื™ื‘ื•ืจ ื“ื•"ื— ื”ืขืจื›ื” ืกืœื•ื‘ืงื™ืช 20-11-2009
ืฆื™ื‘ื•ืจ ื“ื• ืฆื™ื‘ื•ืจ ื“ื•"ื— ื”ืขืจื›ื” ืกืœื•ื‘ื ื™ืช 20-11-2009
ืฆื™ื‘ื•ืจ ื“ื• ืฆื™ื‘ื•ืจ ื“ื•"ื— ื”ืขืจื›ื” ืคื™ื ื™ืช 20-11-2009
ืฆื™ื‘ื•ืจ ื“ื• ืฆื™ื‘ื•ืจ ื“ื•"ื— ื”ืขืจื›ื” ืฉื•ื•ื“ื™ืช 20-11-2009

ื—ื™ืคื•ืฉ ื”ืชืจืื•ืช ื”ืงืฉื•ืจื•ืช ืœืžื•ืฆืจ ื–ื”

ื”ืชืจืื•ืช Milnacipran Pierre Fabre Medicament

Milnacipran Pierre Fabre Medicament

ืฆืคื• ื‘ื”ื™ืกื˜ื•ืจื™ื™ืช ื”ืžืกืžื›ื™ื

ื”ื™ืกื˜ื•ืจื™ื™ืช ื”ืžืกืžื›ื™ื ื”ื™ืกื˜ื•ืจื™ื™ืช ื”ืžืกืžื›ื™ื

Milnacipran Pierre Fabre Medicament